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a protein interacting network, called ‘‘the connexome’’, where molecules classically deﬁned as
belonging to one particular structure (e.g., desmosomes, gap junctions, sodium channel complex)
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adhesion in the heart. The concept of the connexome is then translated into the understanding of
the mechanisms leading to two inherited arrhythmia diseases: arrhythmogenic cardiomyopathy,
and Brugada syndrome. The cross-over points in these two diseases are addressed to then suggest
that, though separate identiﬁable clinical entities, they represent ‘‘bookends’’ of a spectrum of man-
ifestations that vary depending on the effect that a particular mutation has on the connexome as a
whole.
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In 1877, Engelman laid the foundation for decades of work when
he concluded that ‘‘cardiac cells are in direct contact during life but
become independent as they die’’ (quoted byWeidmann, 1952) [1].
Ultrastructural studies later revealed that this ‘‘direct contact’’ is
supported by three structures, present at the site of end-end cell
apposition: gap junctions, desmosomes and adherens junctions.
In the following paragraph we provide a brief historical review of
the discovery of the relation between a structure (gap junctions),
its function (to provide a low-resistive pathway between cells)
and its primary molecule (connexins). Similar historical perspec-
tives can be found in the literature as it pertains to the structures
that provide mechanical coupling between cells (e.g.,) [2].
1.1. Historical overview: the puzzle of separate but connected
The way in which cardiac cells coordinate their independent
activities was a fundamental point of debate in cardiac physiology
for the ﬁrst half of the 20th century. By the early 1950s, two seem-
ingly contradictory results were, on the other hand, stronglysupported by the data: cells were individually wrapped in a cell
membrane (and therefore electrically separate from their neigh-
bors) and yet, the space constant of the cardiac tissue was much
longer than the length of the single cell [1]. The advent of electron
microscopy opened a large window into the cardiac landscape.
After the early description of the intercalated disc as an area of spe-
cialization at the site of cell–cell contact [3] Dewey, Sjostrand and
Andersson proposed (in 1958) [4] that the cardiac intercalated disc
was ‘‘a connecting surface’’, like the one ﬁrst described by Robert-
son in the crayﬁsh [5]. Six years later, the structural observation
was ﬁnally reconciled with functional studies. Vanderkloot and
Dane demonstrated that the intercalated disc was a subdomain
of low electrical resistance. In their article, they speculated that
‘‘One possibility which might account for the low electrical resis-
tance is that the intercalated discs are ‘leaky’ in regions where
there are desmosomes or at the regions of membrane fusion’’ [6].
In 1965, Barr, Dewey and Berger provided the ﬁrst experimental
evidence speciﬁcally linking that ‘‘region of membrane fusion’’
(at that time called the nexus) with the propagation of the action
potential [7]. The notion that ‘‘the nexus’’ was formed by fused
membranes [7,8] was challenged by Revel and Karnovsky who, in
1967 [9], demonstrated that the membranes were not fused but
separated by a gap with interposed junctions, leading Revel to later
coin the term ‘‘gap junctions’’.
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molecules
The discovery in the 1980s of the connexin gene family gave
molecular identity to a well-characterized ultrastructure [10–12].
A molecule-structure–function association was established and
set the foundation for a well-accepted principle: connexins make
gap junctions, which allow for the transfer of charge between car-
diac cells.
The principle stated above never intended to discard the
possibility that connexins have other functions. Yet, with a few
exceptions [13–17], the underlying assumption has been that
connexin-related events are gap junction-related (or at most,
hemichannel-related) events. In contrast, evidence dating back to
the early work of Ross Johnson and his colleagues [18] has consis-
tently pointed to the possibility that connexin, as a molecule, par-
ticipates in cellular processes that are independent of the existence
of a connexin-formed permeable channel. This notion has caught
new speed partly through the ﬁnding of the perinexus [19,20] (re-
viewed in a separate section below), as well as the evidence that
Cx43 can regulate microtubule stability independent of gap junc-
tion formation [15]. It is in the context of these non-canonical func-
tions of connexin [14,21] that we build on the concept of the
connexome.
Connexins are far from being the only multi-tasking molecule at
the intercellular junction. Multiple examples abound, though per-
haps the best studied is the case of beta-catenin, which acts as
an intermediary to regulate transcription as well as cell adhesion
[22]. In the case of desmosomes, the data suggest that they also
act as signaling platforms [2]. Finally, evidence in cardiac, and
non-cardiac cells show that cadherin-rich structures also serve as
a point of capture for microtubule anchoring [23,24]. Overall, the
evidence indicates that individual molecules, as well as the actual
structures of the intercellular junctions exert multiple functions.
The idea of silos of one-molecule-one function (or one structure-
one function) seems not to apply to the intercalated disc. A com-
munal protein interacting network seems a better description of
the way in which the overall function is achieved.
To review all non-canonical functions of junctional molecules
would go beyond the scope of this article. On the other hand, to
limit the review exclusively to intercellular contact molecules
would exclude a very important component of the intercalated
disc, namely, the voltage-gated sodium channel (VGSC) complex
[25,26]. In the next paragraphs we will concentrate on desmo-
somes, gap junctions and the voltage-gated sodium channel
(VGSC) complex, three complexes conventionally associated with
three functions: adhesion, electrical coupling and cell excitability.
Our goal will be to convey the message that molecules classically
deﬁned as belonging to one of the structures are indeed relevant
to the function of the others, so that intercellular adhesion is in
part controlled by connexins and by components of the VGSC com-
plex, sodium current by desmosomal molecules and by connexins
and electrical coupling by the integrity of desmosomes and by the
expression of ankyrin-G (AnkG), a molecule conventionally identi-
ﬁed with sodium channel function [27,28].2. The connexome
2.1. Intercellular adhesion strength depends on molecules ‘‘of the VGSC
complex’’
The ability of cells to adhere tightly to each other depends in
part on the expression of molecules conventionally ascribed to
the VGSC complex. This link was established several years ago
by the Isom lab [29–31]. In 1981, Hartshorne and Catterallpuriﬁed ‘‘the saxotoxin receptor of the sodium channel from
rat brain’’ and identiﬁed two polipeptides, which they referred
to as ‘‘a’’ and ‘‘b’’ [32]. They proposed that these two subunits
conformed the functional sodium channel. In 1992, Lori Isom
isolated the cDNA, sequenced and functionally expressed the
b-1 subunit, concluding that this protein is crucial to the overall
function of the sodium channel. [31] In this manner, this 22581
dalton protein was labeled as a ‘‘b’’ for its ‘‘a’’, a subunit merely
accessory to sodium channel function. It was 5 years later (in
2000) that the Isom lab demonstrated that ‘‘sodium channel beta
subunits’’ also mediate cell adhesion, [33] a fact important not
only in the formation of the sodium channel complex [29,33]
but also in sodium channel-independent functions such as cell
migration, cell aggregation and interaction with the cytoskeleton
(see) [30].
The work described above has been extended to show that
AnkG, a well-established scaffolding protein for the sodium
channel in heart as well as in the nervous system [27,34–36], is
necessary for proper cell adhesion. This was shown by experiments
using an assay where the contact between the cells and the extra-
cellular matrix is disrupted by the use of dispase. If adhesion be-
tween cells is strong, the layer lifts as one sheet (cells remain
attached to one another). If cell–cell adhesion is weaker, the sheet
fragments. Thus, the more fragments, the weaker the mechanical
coupling. Using this method, Sato et al. showed that loss of Ank-
G expression (causes a decrease in mechanical coupling between
cells [37].
The precise contribution of sodium channel beta subunits, or of
AnkG, to the overall adhesion strength of cardiac cells in situ is not
known. But one can speculate that genetic alterations that displace
the beta subunit or AnkG from the intercalated disc could have the
potential of altering myocardial structure. This is particularly rele-
vant in the context of data showing that a mutation in the gene
coding for the alpha subunit of the sodium channels (SCN5a) asso-
ciates with dilated cardiomyopathy [38]. Separate studies have
reported the presence of structural defects in patients with Brug-
ada syndrome [39,40]. This important link between adhesion and
sodium current function will be extensively discussed in the last
sections of this review.
2.2. Intercellular adhesion is impaired by loss of ‘‘gap junction
proteins’’
More than twenty years ago Ross Johnson and his colleagues
reported that Fab fragments of antibodies to the extracellular do-
main of Connexin43 (Cx43), the most abundant connexin in the
heart, inhibits adherens junction assembly in cells in culture
[18]. More recently, we implemented the dispase assay described
above to compare two cell populations [14]: one, HEK293 cells
that endogenously express Cx43 and another one, a stable
HEK293 line where we used lentivirus to permanently silence
Cx43 expression. Three groups were compared: untreated
(UNT), treated with a virus that contains a non-silencing con-
struct (/shRNA-Cx43) and a third group where Cx43 expression
was prevented (shRNA-Cx43). Loss of Cx43 expression brought
about a loss of intercellular adhesion strength, represented by a
signiﬁcant increase in the number of fragments detected 90 min
after dispase addition [14]. These results show that Cx43 expres-
sion is relevant to mechanical coupling. Whether this effect is
consequent to gap junctions being a physical element that pro-
vides intercellular adhesion, or whether the result involves inter-
molecular interactions between Cx43 and components of the
mechanical junctions, remains to be determined. The results do
show that intercellular adhesion strength is a function of Cx43
that extends beyond the formation of a low-resistive pathway be-
tween cells.
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‘‘of the desmosome’’ or ‘‘of the VGSC complex’’
Shortly after the link between desmosomal mutations and
arrhythmogenic cardiomyopathy (AC) was established, the Safﬁtz
group showed decreased abundance of immunoreactive Cx43 signal
at the intercalated disc in heart samples derived from patients with
Naxos disease [41], with Carvajal syndrome [42] and in general,
with AC [43]. In 2007, Oxford et al. conﬁrmed that the desmosomal
protein PKP2 and Cx43 co-exist in the same macromolecular
complex [44]. Moreover, shRNA-mediated loss of PKP2 expression
in cultured rat ventricular cardiomyocytes led to a reduction in
Cx43 abundance at the site of cell–cell contact, as well as decreased
dye coupling between cells [44]. The observation of an association
between Cx43 and PKP2 was later conﬁrmed by other studies
[45,46]. Furthermore, recent data using super-resolution ﬂuores-
cence microscopy have demonstrated that Cx43 and PKP2 are in
close physical proximity and in fact, PKP2 clusters are often found
within the boundaries of the Cx43 plaque [21]. These results sup-
port the notion of direct modulation of Cx43 by PKP2. Yet, it should
be noted that complete loss of PKP2 causes only a 50% decrease in
gap-junction mediated intercellular coupling [44], and previous
work has demonstrated that this decrease in junctional coupling
is not sufﬁcient to signiﬁcantly affect conduction velocity [47,48].
The extent of electrical coupling between cells is also modiﬁed
by loss of expression of AnkG. Indeed, studying neonatal rat ven-
tricular myocytes in culture, Sato et al. demonstrated that loss of
expression of AnkG led to reduced gap junction conductance
[37]. These results support the notion that AnkG is much more
than a scaffold for sodium channels. Its role may be key in deﬁning
the exact position of various molecules of the connexome so that
they interact with each other in the appropriate subdomain. In fact,
AnkG may be a key piece that controls the trafﬁc of molecules be-
tween the perinexus and the gap junction plaque (illustrated in
Fig. 1).
2.4. Sodium current amplitude is modulated by ‘‘cell adhesion
molecules’’
Early studies showed that the VGSC resides preferentially at the
cardiac intercalated disc [25,26] and that it can be co-precipitated
with Cx43 and with N-cadherin [49]. We therefore explored if dis-
ruption of desmosomal integrity could alter sodium current (INa).
Our studies focused on the desmosomal protein PKP2, given that
(a) PKP2 mutations are the most common variant in AC [50] and
(b) early-onset ventricular ﬁbrillation and sudden death in the ab-
sence of an overt structural cardiomyopathy are often found in
PKP2 mutations carriers [50]. In the ﬁrst demonstration of a rela-
tion between PKP2 and INa, Sato et al. [51] showed that in cardiacAnkG
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Fig. 1. One possible model of connexome organization. The gap junction is surrounded b
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conductance. From [21] with permission.myocytes lacking PKP2, INa was signiﬁcantly decreased. Further-
more, loss of PKP2 expression in cardiac myocytes led to decreased
abundance of immunoreactive Nav1.5 (the a-subunit of the VGSC)
at sites of cell contact, and optical mapping experiments showed
increased reentrant activity and signiﬁcantly decreased conduction
velocity in the absence of PKP2, when compared to controls [51]. A
subsequent study showed that the cytoskeletal adaptor protein
Ankyrin-G (AnkG) may play a key role in allowing for the interac-
tion between three molecular components previously considered
independent: the desmosome, the gap junction, and the VGSC
complex [37]. These observations, limited to the cellular/molecular
levels, prompted us to investigate the susceptibility to VGSC-
dependent arrhythmias in hearts deﬁcient in PKP2.
Patients affected with AC carry loss of function mutations in a
heterozygous fashion. We therefore studied a mouse model with
PKP2 haplo-insufﬁciency (PKP2-Hz), which mimics the clinical
situation of patients harboring truncating mutations, with an
expected 50% of PKP2 availability [52]. The mouse model did
not show signs of structural cardiomyopathy. Nav1.5 protein
abundance was not altered and yet, the amplitude of INa in isolated
ventricular cardiomyocytes was signiﬁcantly decreased. Further-
more, there was a shift in gating and INa kinetics when compared
to wild-type cardiomyocytes [52]. Thus, intrinsic, genetically
mediated partial loss of PKP2 was able to affect sodium current
amplitude, similarly to what was demonstrated in cells after total
loss of PKP2 expression.
To further unmask the consequences of INa deﬁcit, we chal-
lenged the PKP2-Hz mouse model with ﬂecainide. All treated ani-
mals showed an increased sensitivity to drug-induced atrial and
ventricular conduction prolongation, showing marked increased
P wave, PR and QRS interval durations and increased conduction
velocities in Langendorff-perfused isolated hearts. Furthermore,
ﬂecainide injection in vivo caused ventricular arrhythmias and
some cases of sudden death in PKP2-Hz animals but not in the
wild-types [52]. These results demonstrated that PKP2 haploinsuf-
ﬁciency causes reduced INa in murine hearts, documenting for the
ﬁrst time the relationship between PKP2 and the VGSC in vivo.
2.5. Additional studies on the relation between adhesion molecules and
the VGSC complex
Separate studies have conﬁrmed the relation between desmo-
somal integrity, and the structure and/or function of the VGSC
complex. Rizzo et al. showed prolonged ventricular activation time,
decreased conduction velocity, decreased upstroke velocity and
decreased INa amplitude in mice over-expressing a mutation in
desmoglein2 [53]. Gomes et al. [54] reported that patients with
AC harboring desmoplakin mutations showed regional conduction
delay and heterogeneous Nav1.5 distribution; moreover, in a 
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from patients with AC, Noorman and colleagues showed that in
most cases, Nav1.5 was reduced at the intercalated disc, even if
the distribution of the N-cadherin signal remained normal. Finally,
reduced sodium current amplitude has been observed in PKP2-
deﬁcient HL1 cells and in induced pluripotent stem cell-derived
cardiomyocytes (iPSC-CMs) from a patient with PKP2 deﬁciency
[56,57].
Though not a desmosomal molecule, the coxsackievirus and
adenovirus receptor CAR is another case of an adhesion molecule
that also regulates sodium current. Undoubtedly a receptor for
both coxsackievirus and adenovirus, studies have demonstrated
that the immunoglobulin extracellular domains of CAR are capable
of homophilic binding, and participate in intercellular adhesion in
epithelial cells. The role of this molecule on cell adhesion in the
heart is less well deﬁned. Interestingly, cardiac-restricted deletion
of CAR causes signiﬁcant slowing of A–V propagation and disrup-
tion of gap junctions at the intercalated disc [58,59]. Recent studies
show that, as in the case of other molecules with immunoglobulin
extracellular domains (such as the sodium channel b-subunits),
CAR expression modulates sodium current function [60].
2.6. Sodium current depends on ‘‘the gap junction protein’’ Connexin43
In the classical description of the electrophysiology of the adult
ventricle, sodium channels provide the current that is necessary for
the generation of an action potential, whereas Cx43 forms gap
junctions to allow transfer of charge between one cell and the next.
This description then separates the type of channel, with its func-
tion: sodium channels are responsible for cell excitability; gap
junctions allow cell–cell passage of charge. In a recent study, how-
ever, we reported that loss of Cx43 expression brings about a loss
of sodium current amplitude [61]. In other words, the molecule
necessary for making the gap junctions is actually necessary to
maintain the complex in charge of generating the action potential.
This means that loss of Cx43 expression is in fact a double-edge
sword: not only will the path between cells be disrupted but also,
the amount of charge that is generated by the excited cell will de-
crease. These results were consistent with others obtained in fetal
atrial myocytes [62] and led to the conclusion that loss and/or
redistribution of Cx43 expression, as it happens in a number of
pathological cardiac conditions (e.g., [63–65]), can have complex
deleterious effects on propagation.
Recent studies conﬁrmed and expanded the importance of
Cx43 in the control of sodium current amplitude. Lubkemeier
et al. [66] developed a conditional knock-in murine model
where, upon tamoxifen injection, the wild-type Cx43 was re-
placed, speciﬁcally in the heart, by a truncated form lacking
the last ﬁve amino acids of the protein (Cx43D378stop). Interest-
ingly, the Cx43D378stop protein forms gap junctions of normal
junctional conductance, unitary conductance and permselectivity.
Localization of Cx43 was not affected by the mutation, nor did it
affect the localization of the ZO-1 protein (known to associate to
Cx43 via its C-end). Yet, the animals died within 21 days after
tamoxifen injection, and Holter recordings showed a transition
from normal sinus rhythm to complex ventricular arrhythmias
culminating in ventricular ﬁbrillation and sudden death. Electro-
physiological analysis revealed that, among the observed
changes, there was a signiﬁcant reduction in the amplitude of
INa. This result clearly demonstrated that a key function of
Cx43 is to maintain normal cell electrophysiology and that, even
if gap junctions are present, a loss of Cx43-dependent, gap junc-
tion-independent functions can lead to severe arrhythmias and
death. Studies are in progress to determine the molecular mech-
anism that links Cx43 and the function of the VGSC complex in
the heart.3. Visualizing interacting complexes at the intercalated disc
3.1. Electron microscopy
The results described above provide convincing evidence of a
functional interaction between the various molecules that reside
at the intercalated disc. Furthermore, it is likely that these interac-
tions are, in fact, far more complex. Using tomographic electron
microscopy (TEM) we have observed structural features that likely
carry unknown functions. For example, it is common to see actual
physical contact between gap junctions and the outer membrane
of mitochondria [67] (Fig. 2). It is also common to observe exten-
sive vesicular activity localized speciﬁcally at the space separating
desmosomes and gap junctions [67] (Fig. 3) and in fact, the pres-
ence of small membranous particles in the intercellular space.
The intercalated disc is, structurally and functionally, not a simple
aggregate of independent, separate complexes but the host of a
protein interacting network.
3.2. Super-resolution ﬂuorescence microscopy
A limitation of electron microscopy is that complexes that do
not form electron-dense structures cannot be visualized. On the
other hand, the resolution of light microscopy is limited by the dif-
fraction of light [68,69] reaching to approximately 250 nm in the
best of conditions and therefore not sufﬁcient to assess the actual
distances betweenmolecules. To overcome this limitation, we have
implemented super-resolution ﬂuorescence microscopy methods
[21,69]. We built a set-up on a conventional inverted microscope
using commercially available optics and applied laser illumination,
reducing, and oxygen scavenging conditions to manipulate the
blinking behavior of individual ﬂuorescent reporters. Movies of
blinking ﬂuorophores were reconstructed to generate subdiffrac-
tion images at 20 nm resolution. We mapped a molecule classi-
cally deﬁned as a component ‘of the desmosome’ (PKP2) and
another one deﬁned as a ‘gap junction molecule’ (Cx43), and de-
ﬁned their spatial organization. As shown in Fig. 4 [21], in about
half of Cx43 clusters we observed an overlay of Cx43 and PKP2 at
the Cx43 plaque edge. SiRNA-mediated loss of Ankyrin-G expres-
sion yielded larger Cx43 clusters, of less regular shape, and larger
Cx43-PKP2 subdomains. The Cx43-PKP2 subdomain was validated
by a proximity ligation assay (PLA) and by Monte-Carlo simula-
tions indicating an attraction between PKP2 and Cx43. Overall
our studies led us to conclude that super-resolution ﬂuorescence
microscopy, complemented with Monte-Carlo simulations and
PLAs, allows the study of the nanoscale organization of an interac-
tome in cardiomyocytes. Our results further showed that PKP2 and
Cx43 share a common hub that permits direct physical interaction.
These results allowed us to fully support the notion that not only
are molecules functionally interacting into what we dubbed a con-
nexome, but they also occupy a common space at the intercellular
junction [21]. The actual location of this space within the context
of the overall intercalated disc architecture may be related to the
studies characterizing the perinexus, as described below.4. The perinexus and the connexome
Recent studies have shown that the association of Cx43 with
its scaffolding protein ZO1 occurs in the periphery of the Cx43
plaque (the ‘‘perinexus’’ [19,20]) and that loss of the interaction
with ZO-1 leads to larger gap junction plaques, with a loss of the
perinexal domain. In a recent study, the Gourdie group further
proposed that the perinexus could be a site for the interaction
of Cx43 with Nav1.5 [19]. From that perspective, the perinexus
could be the site of the connexome. This is an interesting
Fig. 2. Proximity between gap junctions and mitochondria. Transmission electron micrograph image of adult murine heart tissue. The high preservation of structures was
achieved by high-pressure freezing and freeze-substitution methods. Notice the close approximation and contact (yellow arrow) between the gap junction and a
mitochondria. From [67] with permission.
Fig. 3. Vesicular activity at the intercalated disc. Tomographic electron microscopy image of an intercalated disc region. Notice the vesicular activity in the space between the
desmosomes and the gap junction, as well as in the intercellular space. From [67] with permission.
1326 E. Agullo-Pascual et al. / FEBS Letters 588 (2014) 1322–1330possibility, which in fact suggests that changes in the stability of
the Cx43-ZO-1 association could actually affect the properties of
INa. Deﬁning the conﬁnes of the perinexus in adult cardiac tissue,
and the molecular constrains that regulate its composition and
its properties represent an important challenge for the future.
It is worth noting that an additional structure in the intercalated
disc that could host multiple molecules is the area composita
[70]. Various investigators have demonstrated that these struc-
tures represent a combination of molecules classically deﬁned
as belonging to the desmosome or to the adherens junctions
[71,72]. We speculate that Cx43 and Nav1.5 may also be found
in the area composita, and interact within that domain. These
two locations (the perinexus or the area composita) are not
mutually exclusive but rather, complementary sites that couldensure the proper integration of the connexome with both, mol-
ecules involved in mechanical function, and in electrical coupling
between cells.
5. Brugada syndrome and AC: two diseases with a common
substrate
Through the writing above, we have sought to establish that the
intercalated disc hosts a common protein interacting network
(the connexome) that includes molecules of the desmosome and
of the VGSC complex. In the clinical realm, desmosomal mutations
lead to AC [73] and sodium channel dysfunction, to Brugada
syndrome [74,75]. We surmised that if the molecular substrates
(desmosomes; VGSC) are part of a common network, then the
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following section, we ﬁrst give a brief description of the two dis-
eases and then, discuss their similarities.
5.1. Arrhythmogenic cardiomyopathy
It is generally accepted that loss of integrity of the desmosome
leads to ‘‘arrhythmogenic cardiomyopathy’’ or ‘‘AC’’. (Also called
‘‘arrhythmogenic right ventricular cardiomyopathy’’, or ‘‘arrhyth-
mogenic right ventricular dysplasia’’, hence the abbreviations
‘‘ARVD’’ ‘‘ARVC’’ or ‘‘ARVC/D’’ found in the literature to refer to this
disease [76,77].) Approximately 50–70% of the cases of familial AC
associate with a mutation in a desmosomal gene [78,79]. This con-
dition presents with a progressive ﬁbro-fatty inﬁltration, often
more prominent in the right ventricular myocardium, and with a
high propensity to life-threatening ventricular arrhythmias and
progression toward heart failure [76]. It is considered one of the
most relevant causes of juvenile sudden cardiac death, especially
in competitive athletes, and its prevalence ranges from 1:2000 to1:5000 [80]. It is important to emphasize, however, that a number
of cases of unexpected cardiac sudden death occur during the early
or ‘‘concealed’’ phase of the disease, in the absence of overt struc-
tural manifestations [81].
5.2. Brugada syndrome
Brugada syndrome (BrS) is an inherited channelopathy charac-
terized by ST segment elevation of coved morphology in right pre-
cordial leads, increased risk of ventricular tachycardia and
ventricular ﬁbrillation and absence of cardiac structural disease
[75]. Mutations in the gene coding for Nav1.5, the most abundant
sodium channel protein in the heart, account for 20–25% of geno-
type-positive subjects [82], and about 4% of patients carry muta-
tions in the CACNA1c gene. Several other genes have been
associated with sporadic cases of BrS, but each one accounts for
<2% of patients; as such, current guidelines do not support routine
screening on them in the general BrS population [82]. Overall only
25–30% of patients with clinical diagnosis of BrS have a known
1328 E. Agullo-Pascual et al. / FEBS Letters 588 (2014) 1322–1330genotype, implying that additional, still undiscovered genes may
be linked to this disease.
5.3. The intersection of BrS and AC
When BrS was initially described, some investigators proposed
that this condition shared features with arrhythmogenic cardiomy-
opathy (AC), thus opening the possibility that they represent two
poles of a common spectrum ultimately leading to increased risk
of sudden death [83]. In fact, some BrS patients show minor RV
structural abnormalities [40]; furthermore, mutations in SCN5A
have been associated with cases of dilated cardiomyopathy,
[38,84] while desmosomal mutation carriers can experience
ventricular ﬁbrillation and sudden death without overt structural
disease [41,54,81,85,86].
5.4. PKP2 mutations and the BrS phenotype
This phenotypical and molecular crossover led us to investigate
whether desmosomal mutations exist in cases of Brugada syn-
drome [57]. We screened by direct sequencing the PKP2 gene in
a cohort of 200 patients with clinical diagnosis of BrS and no muta-
tions on the most prevalent genes. We discovered ﬁve single amino
acid substitutions in ﬁve unrelated patients [57]. In order to assess
if this missense variant in PKP2 could affect the cardiac INa, we
used an HL-1 cell line, stably silenced for the endogenous PKP2.
In the absence of PKP2, these cells showed a decrease in the native
INa. Cells transiently transfected with each one of the PKP2 mutants
associated with the BrS phenotype showed signiﬁcantly decreased
INa, when compared with cells transfected with wild type PKP2
[57]. Similar results were obtained when we used a line of human
iPSC-derived cardiomyocytes from a patient lacking PKP2 at the
cell membrane [56,87]. In these cells, INa increased upon transfec-
tion with wild type PKP2. Transfection with one of the PKP2 mu-
tants associated with BrS was not able to restore normal INa [57].
These data represent the ﬁrst evidence that missense mutations
in PKP2 can cause a decrease in cardiac INa and facilitate arrhyth-
mias, even in the absence of a structural cardiomyopathy. We
propose that PKP2 mutations provide at least part of the molecular
substrate of BrS. The inclusion of PKP2 as part of routine BrS genet-
ic testing remains premature; yet, the possibility that some pa-
tients showing signs of disease may harbor PKP2 variants should
be considered when the genotype is negative for other genes asso-
ciated with BrS.
6. ARVC, BrS and the diseases of the connexome
In summary, the experimental data support the notion that
rather than controlled by ‘‘individually wrapped’’ separate
molecular complexes, excitability, electrical coupling and inter-
cellular adhesion are controlled by a common protein interacting
network called the connexome. As the edges of the molecular
complexes are blurred, so are the clinical syndromes that associ-
ate with them: Brugada syndrome is not purely arrhythmogenic
(but includes a structural component), arrhythmias in AC are not
only consequent to alterations in macrostructure (molecular
changes in the intercalated disc subdomain, and in sodium cur-
rents, can be found), and in fact, PKP2 mutations can also be the
substrate for BrS. While clinically distinguishable as individual
entities, we propose that they share a common origin as diseases
of the connexome.
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